DISCOUNT OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000MB8MAX2

Delayed Börse Stuttgart 03:29:33 2024-05-23 EDT
0.018 EUR -25.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - MEDTRONIC
1 month+26.32%
3 months-60.00%
Date Price Change
24-05-23 0.018 -25.00%
24-05-22 0.024 0.00%
24-05-21 0.024 -4.00%
24-05-20 0.025 -7.41%
24-05-17 0.027 +3.85%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 03:29 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN MB8MAX
ISINDE000MB8MAX2
Date issued 2023-07-12
Strike 97.5 $
Maturity 2024-06-21 (30 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.33
Lowest since issue 0.013
Spread 0.016
Spread %40.00%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
85.76 USD
Average target price
94.77 USD
Spread / Average Target
+10.51%
Consensus